XML 18 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Jan. 31, 2016
Feb. 01, 2015
Cash flows from operating activities:    
Net income $ 13,333 $ 10,157
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 4,888 4,244
Amortization of other assets 123 140
Stock-based compensation 1,964 482
Excess tax benefit related to stock-based compensation (822) (110)
Deferred income taxes 1,906 3,274
Gain on sale of equipment (66) (74)
Realized loss on sale of short-term investments 127  
Foreign currency gains (85) (6)
Changes in assets and liabilities:    
Accounts receivable 1,091 (3,455)
Inventories (6,485) 2,536
Other current assets (108) (739)
Other assets 48 (30)
Accounts payable - trade (1,979) 2,267
Accrued expenses and deferred compensation 1,406 2,121
Income taxes 535 (108)
Net cash provided by operating activities 15,876 20,699
Cash flows from investing activities:    
Capital expenditures (7,686) (8,185)
Proceeds from the sale of equipment 230 625
Proceeds from the sale of life insurance policies   320
Payments on life insurance policies (18) (18)
Proceeds from the sale of short-term investments 5,612 1,628
Purchase of short-term investments (86) (3,719)
Purchase of long-term investments (1,268) (1,298)
Net cash used in investing activities (3,216) (10,647)
Cash flows from financing activities:    
Proceeds from line of credit 7,000  
Payments on line of credit (7,000) (538)
Payments on long-term debt (2,200) (2,200)
Repurchase of common stock (2,397) (745)
Dividends paid (7,281) (6,846)
Payments on debt issuance costs (43)  
Proceeds from common stock issued 138 94
Excess tax benefit related to stock-based compensation 822 110
Net cash used in financing activities (10,961) (10,125)
Effect of exchange rate changes on cash and cash equivalents 289 (458)
Increase (decrease) in cash and cash equivalents 1,988 (531)
Cash and cash equivalents at beginning of period 29,725 [1] 29,303
Cash and cash equivalents at end of period $ 31,713 $ 28,772
[1] Derived from audited financial statements.